Coronavirus Vaccine News Headlines
227 Latest Update On Coronavirus Vaccine.Find latest news on Coronavirus Vaccine, Coronavirus Vaccine news latest, Coronavirus Vaccine news today, Coronavirus Vaccine current news and more from various News Websites / Blog / Articles
At present, three coronavirus vaccine candidates are being tested in India.
The Serum Institute of India (SII), Pune, is carrying out Phase 3 trials for the AstraZeneca vaccine in India with about 1,600 participants.
This process of the creation of the database was done ahead of Prime Minister Narendra Modis meeting with the chief ministers of all states on Tuesday on the administration of vaccines.
The Centre has asked states to take steps needed for strengthening surveillance of adverse events following immunisation before the COVID-19 vaccine is introduced, noting that preparations are underwa
While announcing the results, the team, comprising students from Oxford University and researchers from AstraZeneca, said that there were three notable points.
Coronavirus Vaccine: Other drug majors who have announced promising results of clinical trials for an anti-Covid 19 vaccine include Pfizer and Moderna.
Following the release of Oxford-AstraZeneca Coronavirus vaccine's trial results, Adar Poonawalla, CEO and owner of Serum Institute of India (SII), took to Twitter to laud the breakthrough and wrote th
Oil prices extended gains on Monday as traders eyed a recovery in crude demand thanks to successful coronavirus vaccine trials, although prices were contained by renewed lockdowns in several
Russia's President Vladimir Putin told G20 leaders on Saturday that Russia was ready to provide its Sputnik V coronavirus vaccine to other countries who need it.
Coronavirus Covid-19 vaccine in India: Phase 3 human trials of Covaxin are said to be the largest as well as the first phase 3 efficacy study for any Covid-19 vaccine in India.
Coronavirus vaccine update: In India, five potential Covid-19 vaccines are in different stages of trial; two of them are in the third phase.
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.